首页> 外文期刊>Diabetes >Statins Ameliorate Endothelial Barrier Permeability Changes in the Cerebral Tissue of Streptozotocin-Induced Diabetic Rats
【24h】

Statins Ameliorate Endothelial Barrier Permeability Changes in the Cerebral Tissue of Streptozotocin-Induced Diabetic Rats

机译:他汀类药物改善链脲佐菌素诱导的糖尿病大鼠脑组织中的内皮屏障通透性变化。

获取原文
获取原文并翻译 | 示例
           

摘要

Statins may have favorable effects on endothelial barrier function. The effect of rosuvastatin and simvastatin therapy (10 mg/kg) for 5 weeks on blood-brain barrier (BBB), blood-retinal barrier (BRB), and cardiac muscle permeability of streptozotocin-induced diabetic rats was studied. The size-selective permeability of different vascular beds to a group of fluorescein isothiocyanate dextrans of varying molecular weights was measured. The volume of distribution of 250-, 70-, and 40-kDa dextrans in the cerebral tissue of diabetic rats were significantly increased. The volume of distribution of these dextrans in cerebral tissue was normalized by both statins. Diabetes did not significantly alter the BRB, but both statins decreased the volume of distribution of 70- and 40-kDa dextrans in the retina. The volume of distribution of 40 kDa in cardiac muscle was increased in diabetes, and this change was prevented with statin treatment. Treatment with rosuvastatin and meval-onate (150 mg/kg in drinking water for 5 weeks) did not alter the volume of distribution measurements. We concluded that 1) diabetes in rats is associated with significant changes in the BBB permeability; 2) statin treatment improves the endothelial barrier function in cerebral tissue, retina, and cardiac muscle; and 3) this statin effect could not be attributed to HMGCoA reductase inhibition.
机译:他汀类药物可能对内皮屏障功能有有利影响。研究了瑞舒伐他汀和辛伐他汀(10 mg / kg)治疗5周对链脲佐菌素诱导的糖尿病大鼠的血脑屏障(BBB),血视网膜屏障(BRB)和心肌通透性的影响。测量了不同血管床对一组分子量不同的荧光素异硫氰酸酯葡聚糖的尺寸选择性渗透性。糖尿病大鼠脑组织中250 kDa,70 kDa和40 kDa右旋糖酐的分布量显着增加。两种他汀类药物均能使这些右旋糖酐在脑组织中的分布量正常化。糖尿病并未显着改变BRB,但两种他汀类药物均可降低视网膜中70kDa和40kDa右旋糖酐的分布量。在糖尿病中,心肌中40 kDa的分布量增加,他汀类药物治疗可防止这种变化。用瑞舒伐他汀和甲羟戊酸(在饮用水中150 mg / kg持续5周)治疗不会改变分布测量的体积。我们得出的结论是:1)大鼠糖尿病与血脑屏障通透性的显着变化有关; 2)他汀类药物治疗可改善脑组织,视网膜和心肌中的内皮屏障功能; 3)这种他汀类药物的作用不能归因于HMGCoA还原酶的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号